Description

Where do we stand on translating breakthrough science into therapeutic products? The session will feature leaders who have developed products using three of the most promising technology areas -- stem cells, RNA therapeutics and epigenetics. They will discuss progress and issues including selecting productive opportunities, effective crisis management, and progressing from R&D through commercialization of innovation.

Key Takeaways:

  • Explore how innovation and value are increasingly necessary for progress and approval
  • Provide a realistic perspective on the issues and potential solutions from people who have succeeded
  • Review the current state of this breakthrough science and how to apply it

Ability Level: All

Session ID: 2423

myBIO Chatter
Who's Attending (300)

See all